⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3066350 | 0.83 | — | — | |
| SCHEMBL1258369 | 0.80 | GAA (0.55) | — | |
| SCHEMBL16558808 | 0.80 | MGAM (0.55) | — | |
| SCHEMBL3787925 | 0.80 | — | — | |
| SCHEMBL272457 | 0.79 | MGAM (0.48) | — | |
| Formaldehyde SCHEMBL5845336 | 0.79 | MGAM (0.48) | — | |
| SCHEMBL7859418 | 0.79 | GAA (0.48) | — | |
| SCHEMBL76382 | 0.78 | — | — | |
| SCHEMBL54111 | 0.78 | — | — | |
| SCHEMBL434191 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-100453530-C | Compound for inhibiting VCAM-1 expression and pharmaceutical composition thereof | ATHEROGENICS INC (US) | 2009-01-21 | — | — | CN | claimed |
| CN-101284808-A | Compounds and methods for the inhibition of the expression of VCAM-1 | ATHEROGENICS INC (US) | 2008-10-15 | — | — | CN | claimed |
| CN-1263522-A | Compounds and methods for inhibiting VCAM-1 expression | ATHEROGENICS INC (US) | 2000-08-16 | — | — | CN | claimed |
| CN-101686676-A | Methods and compositions of derivatives of probucol for the treatment of diabetes | ATHEROGENICS INC | 2010-03-31 | — | — | CN | disclosed |
| CN-100453530-C | Compound for inhibiting VCAM-1 expression and pharmaceutical composition thereof | ATHEROGENICS INC (US) | 2009-01-21 | — | — | CN | disclosed |
| CN-101284808-A | Compounds and methods for the inhibition of the expression of VCAM-1 | ATHEROGENICS INC (US) | 2008-10-15 | — | — | CN | disclosed |
| CN-100401400-C | Rewritable optical information recording medium and recording/reproducing method, recording/reproducing device | SONY CORP MITSUI CHEMICALS INC (JP) | 2008-07-09 | — | — | CN | disclosed |
| CN-100384943-C | The use of aromatic compounds as phase directors and particle size reducers for quinacridone pigments | CIBA SC HOLDING AG (CH) | 2008-04-30 | — | — | CN | disclosed |
| CN-1311988-C | Imide compounds and optical recording media made by using the same | MITSUI CHEMICALS INC (JP) | 2007-04-25 | — | — | CN | disclosed |
| CN-1867980-A | Optical recording medium and compound for use in the same | MITSUI CHEMICALS INC (JP) | 2006-11-22 | — | — | CN | disclosed |
| CN-1224524-C | Benzodiazolyl compound, and compound for optical recording medium | MITSUI CHEMICALS INC (JP) | 2005-10-26 | — | — | CN | disclosed |
| CN-1575236-A | Imide compounds and optical recording media made by using the same | MITSUI CHEMICALS INC OGISO AKI (JP) | 2005-02-02 | — | — | CN | disclosed |
| CN-1501964-A | The use of aromatic compounds as phase directors and particle size reducers for quinacridone pigments | �������⻯ѧƷ�ع�����˾ | 2004-06-02 | — | — | CN | disclosed |
| CN-1434771-A | Optical recording medium and azaporphyrin compound | MITSUI CHEMICALS INC (JP) | 2003-08-06 | — | — | CN | disclosed |
| CN-1406182-A | Benzodiazolyl compound, optical recording medium compound | MITSUI CHEMICALS INC (JP) | 2003-03-26 | — | — | CN | disclosed |
| CN-1338738-A | Optical recording media and porphinoid compound | MITSUI CHEMICALS INC (JP) | 2002-03-06 | — | — | CN | disclosed |
| US-6248161-B1 | Preparation of permanent color inks from water-soluble colorants using specific phosphonium salts | HEWLETT-PACKARD COMPANY | 2001-06-19 | — | — | US | disclosed |
| CN-1263522-A | Compounds and methods for inhibiting VCAM-1 expression | ATHEROGENICS INC (US) | 2000-08-16 | — | — | CN | disclosed |
| CN-1133859-A | Stabilizer combination | CIBA GEIGY AG (CH) | 1996-10-23 | — | — | CN | disclosed |
| CN-1091288-A | The oxytocin antagonist | OTSUKA PHARMA CO LTD (JP) | 1994-08-31 | — | — | CN | disclosed |